ZEB1-Mediated ATPAF1 Repression Impairs ATP Synthase Assembly and Promotes Tubular Epithelial Plasticity in CKD
Background: Mitochondrial metabolic defects contribute to chronic kidney disease (CKD) progression, but whether profibrotic signaling directly disrupts adenosine triphosphate (ATP) synthase assembly and promotes tubular epithelial plasticity remains unclear. Methods: We examined mitochondrial remodeling during transforming growth factor-β (TGFβ)-induced epithelial-mesenchymal transition (EMT) in renal tubular epithelial cells. Findings were evaluated in mouse kidney fibrosis models and human CKD biopsies. Results: TGFβ reduced ATP synthase (complex V) activity, ATP-linked respiration, and ATP production while increasing mitochondrial membrane potential; complex I–III, II–III, and IV activities were preserved. TGFβ induced zinc finger E-box-binding homeobox 1 (ZEB1)-dependent repression of ATP synthase assembly factor 1 (ATPAF1), impairing ATP synthase assembly. ATPAF1 knockdown reduced ATP synthase assembly and mitochondrial bioenergetic capacity and induced EMT-associated molecular and morphological changes. Conversely, ATPAF1 overexpression restored ATP synthase assembly, ATP production, and respiratory function and attenuated TGFβ-induced EMT-associated changes. ATP supplementation also attenuated TGFβ-induced EMT-associated marker changes. Injured tubules in fibrotic mouse kidneys exhibited reduced ATPAF1 expression and defective ATP synthase assembly, whereas liposome-mediated ATPAF1 plasmid delivery attenuated tubular injury and fibrotic remodeling. In human CKD biopsies, tubular ATPAF1 expression declined with advancing disease and was associated with mitochondrial structural abnormalities. Conclusions: ZEB1-dependent ATPAF1 repression impaired ATP synthase assembly and mitochondrial bioenergetics during TGFβ-induced epithelial plasticity. ATPAF1 perturbation and ATP supplementation findings supported reduced ATP availability as a contributor to EMT-associated changes, rather than elevated mitochondrial membrane potential as a direct driver.
Authors
- Ai‐Ning Shao (ORCID: https://orcid.org/0000-0001-5359-906X)
- Hui‐Kuan Lin (ORCID: https://orcid.org/0000-0002-3501-2410)
- Pei-Jane Tsai (ORCID: https://orcid.org/0000-0002-3370-9839)
- Jhih-Kai Pan (ORCID: https://orcid.org/0000-0002-1244-283X)
- Kuan‐Hung Liu (ORCID: https://orcid.org/0000-0001-5988-6123)
- Sy‐Ying Leu
- Ching-Chun Yang
- Junne‐Ming Sung (ORCID: https://orcid.org/0000-0003-1916-7815)
- Shih‐Chieh Lin (ORCID: https://orcid.org/0000-0002-9967-5037)
- Ming‐Jer Tang (ORCID: https://orcid.org/0000-0002-0883-4363)
- Chia‐Jung Li (ORCID: https://orcid.org/0000-0002-3773-9015)
- Lee PoTsang
- Pei‐Jung Lu (ORCID: https://orcid.org/0000-0002-8143-5668)
- Yau-Sheng Tsai (ORCID: https://orcid.org/0000-0002-5560-2661)
- Wen-Chung Chen
- Shang-Rung Wu (ORCID: https://orcid.org/0000-0003-1940-7612)
- Yi-Ting Shen (ORCID: https://orcid.org/0009-0000-2751-312X)
Institutions
- National Sun Yat-sen University (TW)
- Duke Medical Center (US)
- Sin-Lau Christian Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- National Cheng Kung University Hospital (TW)
- Wake Forest University (US)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Journal of the American Society of Nephrology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1681/asn.0000001325
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00